Kidere D

From Bioblast
(Redirected from Kidere Dita)
Jump to: navigation, search



e-COST MitoEAGLE
e-COST MitoEAGLE countries
MitoGlobal
MitoEAGLE
News and Events         About COST Action MitoEAGLE         Working Groups         MitoEAGLE Summit 2020 Obergurgl AT         MitoEAGLE Preprint States and rates         Short-Term Scientific Missions         Inclusiveness Target Countries         Management Committee         Members    


MiPsociety
COST Action CA15203 MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


 

Kidere D


MitoPedia topics: EAGLE 

COST: Member


COST WG4: WG4


MC Substitute - Management Committee MitoEAGLE


Name Kidere Dita, MSc
Institution
Pelnena Dita
Latvian Biomedical Research and Study Centre, LV
Address Ratsupites Street 1, LV-1067
City Riga
State/Province
Country Latvia
Email dita@biomed.lu.lv
Weblink http://biomed.lu.lv/en/about-us/people/dita-pelnena-msc-biol/
O2k-Network Lab

Labels:



Publications

 PublishedReference
Gnaiger 2019 MitoFit Preprint Arch2019Gnaiger E, Aasander Frostner E, Abdul Karim N, Abdel-Rahman EA, Abumrad NA, Acuna-Castroviejo D, Adiele RC, et al (2019) Mitochondrial respiratory states and rates. MitoFit Preprint Arch doi:10.26124/mitofit:190001.v6.
MitoEAGLE blood cells 12018MitoEAGLE blood cells group (2018) An interlaboratory guide through procedures for mitochondrial respiratory studies with intact and permeabilized peripheral blood mononuclear cells and platelets. - Updated: 2018-02-23

Abstracts

 PublishedReference
Kidere 2019 MiP20192019
Dita Kidere
No abstract
Kidere 2018 MiP20182018
Dita Kidere
Cytoplasmic hybrid cells as a model to characterize the effect of the mtDNA mutations on the OXPHOS system.
Kidere 2018 MiPschool Tromso E22018
Dita Kidere
Cytoplasmic hybrid cells as a model to characterize the OXPHOS system: control sample with glutamate metabolism defect.
Pelnena 2016 Abstract MitoFit Science Camp 20162016OXPHOS enzyme activity measurements in mitochondria isolated from peripheral blood leukocytes in control group and patients with suspected mitochondrial disease.

 


Participated at